1. Home
  2. NLSP vs QRTEA Comparison

NLSP vs QRTEA Comparison

Compare NLSP & QRTEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • QRTEA
  • Stock Information
  • Founded
  • NLSP 2015
  • QRTEA 1991
  • Country
  • NLSP Switzerland
  • QRTEA United States
  • Employees
  • NLSP N/A
  • QRTEA N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • QRTEA Catalog/Specialty Distribution
  • Sector
  • NLSP Health Care
  • QRTEA Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • QRTEA Nasdaq
  • Market Cap
  • NLSP 243.8M
  • QRTEA 239.9M
  • IPO Year
  • NLSP 2021
  • QRTEA N/A
  • Fundamental
  • Price
  • NLSP $4.45
  • QRTEA $0.59
  • Analyst Decision
  • NLSP
  • QRTEA
  • Analyst Count
  • NLSP 0
  • QRTEA 0
  • Target Price
  • NLSP N/A
  • QRTEA N/A
  • AVG Volume (30 Days)
  • NLSP 32.7K
  • QRTEA 3.4M
  • Earning Date
  • NLSP 10-18-2024
  • QRTEA 11-07-2024
  • Dividend Yield
  • NLSP N/A
  • QRTEA N/A
  • EPS Growth
  • NLSP N/A
  • QRTEA N/A
  • EPS
  • NLSP N/A
  • QRTEA N/A
  • Revenue
  • NLSP N/A
  • QRTEA $10,371,000,000.00
  • Revenue This Year
  • NLSP N/A
  • QRTEA N/A
  • Revenue Next Year
  • NLSP N/A
  • QRTEA N/A
  • P/E Ratio
  • NLSP N/A
  • QRTEA N/A
  • Revenue Growth
  • NLSP N/A
  • QRTEA N/A
  • 52 Week Low
  • NLSP $4.08
  • QRTEA $0.40
  • 52 Week High
  • NLSP $35.60
  • QRTEA $1.80
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 36.17
  • QRTEA 48.77
  • Support Level
  • NLSP $4.72
  • QRTEA $0.50
  • Resistance Level
  • NLSP $5.36
  • QRTEA $0.65
  • Average True Range (ATR)
  • NLSP 0.56
  • QRTEA 0.05
  • MACD
  • NLSP -0.01
  • QRTEA 0.00
  • Stochastic Oscillator
  • NLSP 19.79
  • QRTEA 43.55

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About QRTEA Qurate Retail Inc. Series A

Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, using their televised shopping programs and via the Internet through their websites and mobile applications; QVC International segment markets and sells a wide variety of consumer products in several foreign countries, using its televised shopping programs and via the Internet through its international websites and mobile applications; and Zulily markets and sells a wide variety of consumer products in the United States and several foreign countries. Geographically, the company operates in U.S, which generates key revenue, Japan, Germany and other regions.

Share on Social Networks: